Stockscreener 앱 받기
2.51
5.02%
0.12
전일 마감가:
$2.39
열려 있는:
$2.39
하루 거래량:
281.83K
Relative Volume:
0.53
시가총액:
$152.04M
수익:
-
순이익/손실:
$-64.86M
주가수익비율:
-2.2411
EPS:
-1.12
순현금흐름:
$-55.66M
1주 성능:
+4.58%
1개월 성능:
+45.09%
6개월 성능:
+97.64%
1년 성능:
+71.92%
1일 변동 폭
$2.385
$2.65
1주일 범위
$2.2501
$2.65
52주 변동 폭
$0.8551
$3.0499
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
명칭
Acumen Pharmaceuticals Inc
전화
617-344-4190
주소
1210-1220 WASHINGTON STREET, NEWTON
Compare ABOS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
2.51 | 144.77M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-07-26 | 개시 | Citigroup | Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-07-20 | 재개 | BofA Securities | Buy |
| 2023-05-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-15 | 개시 | BTIG Research | Buy |
| 2022-06-30 | 개시 | H.C. Wainwright | Buy |
| 2022-01-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-07-26 | 개시 | BofA Securities | Neutral |
| 2021-07-26 | 개시 | Credit Suisse | Outperform |
| 2021-07-26 | 개시 | Stifel | Buy |
| 2021-07-26 | 개시 | UBS | Buy |
모두보기
Acumen Pharmaceuticals Inc 주식(ABOS)의 최신 뉴스
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Sees Significant Increase in Short Interest - MarketBeat
Can Acumen Pharmaceuticals Inc. stock sustain institutional interest2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - mfd.ru
Acumen Pharmaceuticals celebrates team contributions - Traders Union
Brokerages Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Price Target at $6.80 - Defense World
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS) - The Globe and Mail
Acumen Pharmaceuticals (NASDAQ:ABOS) Rating Lowered to Sell at Wall Street Zen - MarketBeat
While Institutions Invested in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Benefited From Last Week's 46% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Acumen Pharma CLO sells $53k in shares after option exercise - Investing.com Canada
Healthcare Stocks Surge in After-Hours Trading - intellectia.ai
Wall Street Analysts Adjust Ratings - intellectia.ai
Assessing Acumen Pharmaceuticals (ABOS) Valuation After New Phase 2 ALTITUDE-AD Trial Developments - Yahoo Finance
Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $7.00 at BTIG Research - MarketBeat
Are Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative? - Sahm
Baker Hughes To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
ABOS: BTIG Raises Price Target to $7.00, Maintains Buy Rating | - GuruFocus
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Acumen Pharmaceuticals’ Share Volatility: Insight Into Recent Developments - StocksToTrade
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS? - Yahoo Finance
Acumen Pharmaceuticals CEO sells shares worth $21993 By Investing.com - Investing.com Nigeria
Acumen Pharmaceuticals CLO sells shares worth $16,720 By Investing.com - Investing.com South Africa
Acumen Pharma CFO Zuga sells shares worth $7.6k By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CEO sells shares worth $21993 - Investing.com
Daniel Joseph Oconnell Sells 9,346 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals CLO sells shares worth $16,720 - Investing.com
Acumen Pharma CMO Siemers sells $5.8k in ABOS stock By Investing.com - Investing.com UK
"Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials - Clinical Leader
January 2026's Rising Stars: Top Penny Stocks To Watch - simplywall.st
VIX Spike: How does Acumen Pharmaceuticals Inc perform in inflationary periods2025 Technical Overview & Smart Swing Trading Techniques - baoquankhu1.vn
EV Market: What is the earnings history of Acumen Pharmaceuticals IncQuarterly Performance Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn
Acumen Pharmaceuticals Inc. (ABOS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - Defense World
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock By Investing.com - Investing.com UK
Acumen Pharma CEO O’Connell sells $47k in shares By Investing.com - Investing.com Canada
Acumen Pharma COO Barton sells $6.5k in shares By Investing.com - Investing.com Canada
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,941 Shares - MarketBeat
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Sells $14,820.26 in Stock - MarketBeat
Insider Selling: Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells 6,888 Shares of Stock - MarketBeat
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock - Investing.com
Acumen Pharmaceuticals, Inc Updates Corporate Presentation with New Data - TradingView
Acumen Pharmaceuticals (NASDAQ:ABOS) Insider Sells $11,769.94 in Stock - Defense World
Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692 - MSN
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Acumen Pharmaceuticals CFO sells shares totaling $56,619 - MSN
Acumen pharma chief regulatory officer sells $2k in shares By Investing.com - Investing.com UK
Acumen Pharma president Doherty sells $15k in ABOS stock By Investing.com - Investing.com Nigeria
Acumen Pharma president Doherty sells $15k in ABOS stock - Investing.com
Acumen pharma chief regulatory officer sells $2k in shares - Investing.com
James Doherty Sells 6,467 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals Inc (ABOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acumen Pharmaceuticals Inc 주식 (ABOS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 28 '26 |
Option Exercise |
1.85 |
2,671 |
4,941 |
176,670 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 26 '26 |
Sale |
3.00 |
15,085 |
45,263 |
173,999 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 28 '26 |
Sale |
3.00 |
2,671 |
8,017 |
173,999 |
1.12%
0.87%
자본화:
|
볼륨(24시간):